Medezine Limited - Period Ending 2018-09-30

Medezine Limited - Period Ending 2018-09-30


Medezine Limited 02349827 false 2017-10-01 2018-09-30 2018-09-30 The principal activity of the company is manufacture of medical appliances. Digita Accounts Production Advanced 6.24.8820.0 Software true false 02349827 2017-10-01 2018-09-30 02349827 2018-09-30 02349827 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2018-09-30 02349827 bus:OrdinaryShareClass2 bus:Non-cumulativeShares 2018-09-30 02349827 bus:OrdinaryShareClass3 bus:Non-cumulativeShares 2018-09-30 02349827 bus:OrdinaryShareClass4 bus:Non-cumulativeShares 2018-09-30 02349827 core:RetainedEarningsAccumulatedLosses 2018-09-30 02349827 core:ShareCapital 2018-09-30 02349827 core:SharePremium 2018-09-30 02349827 core:CurrentFinancialInstruments 2018-09-30 02349827 core:CurrentFinancialInstruments core:WithinOneYear 2018-09-30 02349827 core:FurnitureFittingsToolsEquipment 2018-09-30 02349827 core:LandBuildings 2018-09-30 02349827 bus:SmallEntities 2017-10-01 2018-09-30 02349827 bus:AuditExemptWithAccountantsReport 2017-10-01 2018-09-30 02349827 bus:FullAccounts 2017-10-01 2018-09-30 02349827 bus:SmallCompaniesRegimeForAccounts 2017-10-01 2018-09-30 02349827 bus:RegisteredOffice 2017-10-01 2018-09-30 02349827 bus:Director1 2017-10-01 2018-09-30 02349827 bus:Director2 2017-10-01 2018-09-30 02349827 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2017-10-01 2018-09-30 02349827 bus:OrdinaryShareClass2 bus:Non-cumulativeShares 2017-10-01 2018-09-30 02349827 bus:OrdinaryShareClass3 bus:Non-cumulativeShares 2017-10-01 2018-09-30 02349827 bus:OrdinaryShareClass4 bus:Non-cumulativeShares 2017-10-01 2018-09-30 02349827 bus:PrivateLimitedCompanyLtd 2017-10-01 2018-09-30 02349827 core:ComputerEquipment 2017-10-01 2018-09-30 02349827 core:FurnitureFittingsToolsEquipment 2017-10-01 2018-09-30 02349827 core:LandBuildings 2017-10-01 2018-09-30 02349827 core:LeaseholdImprovements 2017-10-01 2018-09-30 02349827 1 2017-10-01 2018-09-30 02349827 countries:AllCountries 2017-10-01 2018-09-30 02349827 2017-09-30 02349827 core:FurnitureFittingsToolsEquipment 2017-09-30 02349827 core:LandBuildings 2017-09-30 02349827 2016-10-01 2017-09-30 02349827 2017-09-30 02349827 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2017-09-30 02349827 bus:OrdinaryShareClass2 bus:Non-cumulativeShares 2017-09-30 02349827 bus:OrdinaryShareClass3 bus:Non-cumulativeShares 2017-09-30 02349827 bus:OrdinaryShareClass4 bus:Non-cumulativeShares 2017-09-30 02349827 core:RetainedEarningsAccumulatedLosses 2017-09-30 02349827 core:ShareCapital 2017-09-30 02349827 core:SharePremium 2017-09-30 02349827 core:CurrentFinancialInstruments 2017-09-30 02349827 core:CurrentFinancialInstruments core:WithinOneYear 2017-09-30 02349827 core:FurnitureFittingsToolsEquipment 2017-09-30 02349827 core:LandBuildings 2017-09-30 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 02349827

Medezine Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 30 September 2018

Ian Walker & Co
Heworth House
Melrosegate
Heworth
York
YO31 0RP

 

Medezine Limited

Contents

Balance Sheet

1

Notes to the Financial Statements

2 to 6

 

Medezine Limited

(Registration number: 02349827)
Balance Sheet as at 30 September 2018

Note

2018
£

2017
£

Fixed assets

 

Tangible assets

4

9,187

249

Current assets

 

Stocks

5

78,715

44,417

Debtors

6

124,786

136,171

Cash at bank and in hand

 

243,949

166,784

 

447,450

347,372

Creditors: Amounts falling due within one year

7

(201,668)

(112,535)

Net current assets

 

245,782

234,837

Net assets

 

254,969

235,086

Capital and reserves

 

Called up share capital

8

103

103

Share premium reserve

7,485

7,485

Profit and loss account

247,381

227,498

Total equity

 

254,969

235,086

For the financial year ending 30 September 2018 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the Board on 2 May 2019 and signed on its behalf by:
 

.........................................
Richard Noble
Director

.........................................
Peter Carroll
Director

 
     
 

Medezine Limited

Notes to the Financial Statements for the Year Ended 30 September 2018

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Unit 11 Chambers Way
Thornecliffe Business Park
Chapeltown
Sheffield
S35 2PH

These financial statements were authorised for issue by the Board on 2 May 2019.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

Medezine Limited

Notes to the Financial Statements for the Year Ended 30 September 2018

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Computer equipment

3 years straight line

Leasehold improvements

over the life of the lease

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Medezine Limited

Notes to the Financial Statements for the Year Ended 30 September 2018

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 4 (2017 - 4).

4

Tangible assets

Land and buildings
£

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 October 2017

-

2,237

2,237

Additions

7,565

3,000

10,565

At 30 September 2018

7,565

5,237

12,802

Depreciation

At 1 October 2017

-

1,988

1,988

Charge for the year

378

1,249

1,627

At 30 September 2018

378

3,237

3,615

Carrying amount

At 30 September 2018

7,187

2,000

9,187

At 30 September 2017

-

249

249

Included within the net book value of land and buildings above is £7,187 (2017 - £Nil) in respect of short leasehold land and buildings.
 

5

Stocks

2018
£

2017
£

Other inventories

78,715

44,417

 

Medezine Limited

Notes to the Financial Statements for the Year Ended 30 September 2018

6

Debtors

Note

2018
£

2017
£

Trade debtors

 

105,225

108,142

Amounts owed by group undertakings and undertakings in which the company has a participating interest

-

15,082

Prepayments

 

3,404

1,101

Other debtors

 

16,157

11,846

 

124,786

136,171

7

Creditors

Creditors: amounts falling due within one year

Note

2018
£

2017
£

Due within one year

 

Trade creditors

 

98,703

68,861

Amounts owed to group undertakings and undertakings in which the company has a participating interest

59,918

-

Accruals and deferred income

 

15,938

22,493

Other creditors

 

27,109

21,181

 

201,668

112,535

8

Share capital

Allotted, called up and fully paid shares

 

2018

2017

 

No.

£

No.

£

Ordinary shares of £1 each

100

100

100

100

Ordinary 'A' shares of £1 each

1

1

1

1

Ordinary 'B' shares of £1 each

1

1

1

1

Ordinary 'C' shares of £1 each

1

1

1

1

 

103

103

103

103

9

Financial commitments, guarantees and contingencies

Amounts not provided for in the balance sheet

The total amount of financial commitments not included in the balance sheet is £132,607 (2017 - £Nil).

 

Medezine Limited

Notes to the Financial Statements for the Year Ended 30 September 2018

10

Parent and ultimate parent undertaking

The company's immediate parent is Medezine Holdings Limited, incorporated in England and Wales.